Bohai Pharmaceuticals Group (OTC:BOPH) announced today that it will release financial results for its Fiscal Year 2011 second quarter ended December 31, 2010 before the market opens on Monday, February 14 and host a conference call on Monday, February 14, 2011, at 11:00 a.m. Eastern to discuss the financial results for its fiscal second quarter ended December 31, 2010.The teleconference can be accessed by dialing 877-407-8031 when calling within the United States or 201-689-8031 when calling internationally. Please dial in 10 minutes prior to the beginning of the call. There will be a playback available until March 5, 2011. To listen to the playback dial 877-660-6853 when calling within the United States, or 201-612-7415 when calling internationally and use account number: 286, in conjunction with replay ID number: 367173.
The conference call will be simultaneously webcast and available on the company's website, www.bohaipharma.com, under the "Events and Presentations" tab of the "Investors" section.
Based in the city of Yantai, Shandong Province, China, Bohai Pharmaceuticals is engaged in the production, manufacturing and distribution of herbal pharmaceuticals based on Traditional Chinese Medicine in China. Bohai's medicines address common health problems such as rheumatoid arthritis, viral infections, gynecological diseases, cardio vascular issues and respiratory diseases. Bohai's products are sold either by prescription through hospitals or over-the-counter through local pharmacies and retail drug store chains.
Bohai has approximately 600 employees, including approximately 300 sales representatives, operating from 20 offices throughout China. Bohai's three lead products, Tongbi Capsules, Tongbi Tablets and Lung Nourishing Cream, are eligible for reimbursement under China's National Medical Insurance Program.
For additional information, please visit Bohai's corporate website: www.bohaipharma.com.
No comments:
Post a Comment